PHILADELPHIA, PA--(Marketwire - September 02, 2010) - Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, is scheduled to participate in the following upcoming investor conferences:
Event: Stifel Nicolaus Healthcare Conference
Date: Thursday, September 16, 2010
Time: 10:20 a.m. ET
Location: Four Seasons Hotel
200 Boylston Street
Boston, Mass.
Speaker: Gearóid Faherty, Chairman and Chief Executive Officer
Event: UBS Global Life Sciences Conference
Date: Monday, September 20, 2010
Time: 9:00 a.m. ET
Location: Grand Hyatt Hotel
Park Avenue at Grand Central
New York, N.Y.
Speaker: John Fraher, Chief Commercial Officer
An audio webcast of the Company's presentations at each conference will be available by accessing the investor relations section of www.eurand.com and will be available via replay for 30 days following the date of the presentation.
About Eurand
Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies. Eurand has had six products approved by the FDA since 2001 and has a pipeline of product candidates in development for itself and its collaboration partners. Its technology platforms include bioavailability enhancement of poorly soluble drugs, custom release profiles and taste-masking orally disintegrating tablet (ODT) formulations. Eurand is a global company with facilities in the U.S. and Europe. For more information, visit www.eurand.com.
Contacts:
Bill Newbould
Vice President, Investor Relations
Eurand N.V.
+1-267-759-9335
Email Contact
Nick Laudico/Sara Pellegrino
The Ruth Group
+1-646-536-7030/7002
Email Contact
Email Contact
